HNI (HNI) has been on a downward spiral lately with significant selling pressure. After declining 25.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in ...
Olema Pharmaceuticals, Inc. (OLMA) has been beaten down lately with too much selling pressure. While the stock has lost 33.4% over the past four weeks, there is light at the end of the tunnel as it is ...